Sohm, Inc, a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, has accelerated its presence in emerging global drug markets by pursuing acquisitions in under-represented, high growth global generic pharmaceutical markets. Sohm has targeted companies that have an established customer base and positive cash flow with an acquisition pipeline focusing on accretive partnerships that contribute significant cash flow and minimize shareholder dilution.
"We are in the fortunate position of being able to make strategic acquisitions as we move to grow our current portfolio of pharmaceutical products in emerging markets," stated vice president for corporate Strategy at Sohm, Inc. "We are open to discussions with companies that are performing well in Southeast Asia, Africa, and Latin America, with particular attention to niche markets in India. Our strengths in product selection, branding, marketing and distribution are highly complementary to our acquisition targets and we expect closure on a series of partnerships in 2009."
Sohm is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories.